Kiwamu Okita

Kiwamu Okita's AcademicInfluence.com Rankings

Kiwamu Okita

Philosophy

#7723

World Rank

#10974

Historical Rank

Logic

#4762

World Rank

#6091

Historical Rank

philosophy Degrees

Download Badge

Philosophy

Kiwamu Okita's Degrees

PhD Medicine University of Tokyo
Doctorate Medicine University of Tokyo

Why Is Kiwamu Okita Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Kiwamu Okita's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients. (2006) (758)
Results of surgical and nonsurgical treatment for small‐sized hepatocellular carcinomas: A retrospective and nationwide survey in Japan (2000) (715)
Transplantation of bone marrow cells reduces CCl4‐induced liver fibrosis in mice (2004) (545)
Improved Liver Function in Patients with Liver Cirrhosis After Autologous Bone Marrow Cell Infusion Therapy (2006) (487)
Phase III study of sorafenib after transarterial chemoembolisation in Japanese and Korean patients with unresectable hepatocellular carcinoma. (2011) (485)
Risk factors for hepatocellular carcinoma and its incidence after interferon treatment in patients with chronic hepatitis C (1998) (476)
Geographic distribution of hepatitis B virus (HBV) genotype in patients with chronic HBV infection in Japan (2001) (424)
Reevaluation of prognostic factors for survival after liver resection in patients with hepatocellular carcinoma in a Japanese nationwide survey (2004) (423)
Report of the 17th Nationwide Follow‐up Survey of Primary Liver Cancer in Japan † (2007) (398)
Comparison of the outcomes between an anatomical subsegmentectomy and a non-anatomical minor hepatectomy for single hepatocellular carcinomas based on a Japanese nationwide survey. (2008) (315)
A urease-negative mutant of Helicobacter pylori constructed by allelic exchange mutagenesis lacks the ability to colonize the nude mouse stomach (1994) (303)
Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial (2019) (298)
Development of evidence‐based clinical guidelines for the diagnosis and treatment of hepatocellular carcinoma in Japan (2008) (296)
Morphologic studies of the liver cell dysplasia (1983) (255)
Phase 2 study of lenvatinib in patients with advanced hepatocellular carcinoma (2016) (255)
GENERAL RULES FOR RECORDING ENDOSCOPIC FINDINGS OF ESOPHAGOGASTRIC VARICES (2ND EDITION) (2010) (235)
BCAA-enriched snack improves nutritional state of cirrhosis. (2007) (206)
Efficacy of lamivudine for preventing hepatocellular carcinoma in chronic hepatitis B: A multicenter retrospective study of 2795 patients. (2005) (193)
Genetic aberrations detected by comparative genomic hybridization in hepatocellular carcinomas: Their relationship to clinicopathological features (1999) (189)
Endoscopic therapy for early colon cancer: the strip biopsy resection technique. (1991) (189)
Report of the 15th follow-up survey of primary liver cancer. (2005) (188)
Endoscopic resection of early gastric cancer. (1993) (182)
An in vivo model for monitoring trans-differentiation of bone marrow cells into functional hepatocytes. (2003) (180)
Clinical efficacy of lactulose in cirrhotic patients with and without subclinical hepatic encephalopathy (1997) (167)
Surgical resection vs. percutaneous ablation for hepatocellular carcinoma: a preliminary report of the Japanese nationwide survey. (2009) (167)
A blind comparison of the effectiveness of endoscopic ultrasonography and endoscopy in staging early gastric cancer (1999) (163)
Hepatitis C virus-induced reactive oxygen species raise hepatic iron level in mice by reducing hepcidin transcription. (2008) (160)
Overexpression of alpha enolase in hepatitis C virus‐related hepatocellular carcinoma: Association with tumor progression as determined by proteomic analysis (2005) (156)
Pioglitazone prevents hepatic steatosis, fibrosis, and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined diet. (2004) (154)
Endoscopic ultrasonography and endoscopy for staging depth of invasion in early gastric cancer: a pilot study. (1997) (152)
Differentiation of Human and Mouse Embryonic Stem Cells along a Hepatocyte Lineage (2004) (147)
Herbal medicine Inchin-ko-to (TJ-135) prevents liver fibrosis and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined diet. (2003) (146)
New small animal model for human gastric Helicobacter pylori infection: success in both nude and euthymic mice. (1991) (144)
Characteristics of patients with chronic hepatitis C who develop hepatocellular carcinoma after a sustained response to interferon therapy (2004) (140)
Leptin enhances TNF-α production via p38 and JNK MAPK in LPS-stimulated Kupffer cells (2005) (135)
Hepatic iron overload induces hepatocellular carcinoma in transgenic mice expressing the hepatitis C virus polyprotein. (2006) (134)
Clinical characteristics, treatment, and prognosis of non-B, non-C hepatocellular carcinoma: a large retrospective multicenter cohort study (2014) (134)
A fundamental study of normal layer structure of the gastrointestinal wall visualized by endoscopic ultrasonography. (1986) (131)
Management of hepatocellular carcinoma in Japan (2006) (130)
Proteomic profiling of heat shock protein 70 family members as biomarkers for hepatitis C virus‐related hepatocellular carcinoma (2003) (128)
Proteomics finding heat shock protein 27 as a biomarker for resistance of pancreatic cancer cells to gemcitabine. (2007) (126)
Tolvaptan for improvement of hepatic edema: A phase 3, multicenter, randomized, double‐blind, placebo‐controlled trial (2014) (122)
Long-term follow-up of large flat colorectal tumors resected endoscopically. (2003) (121)
Safety and Pharmacokinetics of Lenvatinib in Patients with Advanced Hepatocellular Carcinoma (2015) (120)
Proteomic profiling of proteins decreased in hepatocellular carcinoma from patients infected with hepatitis C virus (2004) (115)
Expression of glycolytic enzymes is increased in pancreatic cancerous tissues as evidenced by proteomic profiling by two-dimensional electrophoresis and liquid chromatography-mass spectrometry/mass spectrometry. (2007) (111)
Cell Death Induced by Baicalein in Human Hepatocellular Carcinoma Cell Lines (1996) (108)
Urease Plays an Important Role in the Chemotactic Motility of Helicobacter pylori in a Viscous Environment (1998) (105)
REFLECT—a phase 3 trial comparing efficacy and safety of lenvatinib to sorafenib for the treatment of unresectable hepatocellular carcinoma: an analysis of Japanese subset (2019) (99)
Differences in hypervariable region 1 quasispecies of hepatitis C virus in human serum, peripheral blood mononuclear cells, and liver (1999) (96)
Diagnostic utility of 20-megahertz linear endoscopic ultrasonography in early gastric cancer. (1996) (96)
Simple genotype analysis of the Asp299Gly polymorphism of the Toll‐like receptor‐4 gene that is associated with lipopolysaccharide hyporesponsiveness (2002) (92)
The prolyl 4‐hydroxylase inhibitor HOE 077 prevents activation of Ito cells, reducing procollagen gene expression in rat liver fibrosis induced by choline‐deficient L‐amino acid‐defined diet (1996) (92)
Matrix metalloproteinase-7 and matrix metalloproteinase-9 are associated with unfavourable prognosis in superficial oesophageal cancer (2003) (91)
Association of the −173 G/C polymorphism of the macrophage migration inhibitory factor gene with ulcerative colitis (2004) (85)
Percutaneous radiofrequency ablation therapy with combined angiography and computed tomography assistance for patients with hepatocellular carcinoma (2001) (85)
Interglandular cytogenetic heterogeneity detected by comparative genomic hybridization in pancreatic cancer. (2002) (84)
Leptin enhances TNF-alpha production via p38 and JNK MAPK in LPS-stimulated Kupffer cells. (2005) (81)
Endoscopic ultrasonography of superficial esophageal cancers using a thin ultrasound probe system equipped with switchable radial and linear scanning modes. (1996) (81)
Association between severity of type A hepatitis and nucleotide variations in the 5` non-translated region of hepatitis A virus RNA: strains from fulminant hepatitis have fewer nucleotide substitutions (2002) (81)
Epstein-Barr Virus Promotes Epithelial Cell Growth in the Absence of EBNA2 and LMP1 Expression (1999) (80)
Endoscopic ultrasonography for diagnosis of submucosal invasion in early gastric cancer (2000) (80)
Establishment of a small animal model for human Helicobacter pylori infection using germ-free mouse. (1994) (80)
Significance of Strip Biopsy, with Particular Reference to Endoscopic “Mucosectomy” (1989) (79)
A modified Japan Integrated Stage score for prognostic assessment in patients with hepatocellular carcinoma (2006) (79)
Inhibitory effects of the herbal medicine Sho-saiko-to (TJ-9) on cell proliferation and procollagen gene expressions in cultured rat hepatic stellate cells. (1998) (79)
Hepatitis C virus RNA in saliva (1990) (76)
Report of the 16th follow-up survey of primary liver cancer. (2005) (76)
Percutaneous radiofrequency ablation therapy for patients with hepatocellular carcinoma during occlusion of hepatic blood flow (2002) (75)
Augmenter of liver regeneration (ALR) may promote liver regeneration by reducing natural killer (NK) cell activity in human liver diseases (2000) (73)
Proteomic analysis of autoantibodies in patients with hepatocellular carcinoma (2006) (73)
Interferon treatment improves survival in chronic hepatitis C patients showing biochemical as well as virological responses by preventing liver‐related death (2004) (73)
Multislice Dynamic MRI of Hepatic Tumors (1993) (73)
Peretinoin after curative therapy of hepatitis C-related hepatocellular carcinoma: a randomized double-blind placebo-controlled study (2014) (72)
Herbal medicine Sho-saiko-to (TJ-9) prevents liver fibrosis and enzyme-altered lesions in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined diet. (1998) (72)
The successive strip biopsy partial resection technique for large early gastric and colon cancers. (1992) (70)
The effect of a late evening snack in patients with liver cirrhosis. (2005) (69)
Epstein–Barr virus infection in non‐carcinomatous gastric epithelium (1997) (69)
Anti-growth effects with components of Sho-saiko-to (TJ-9) on cultured human hepatoma cells. (1993) (67)
A Comparison of DNA Copy Number Changes Detected by Comparative Genomic Hybridization in Malignancies of the Liver, Biliary Tract and Pancreas (2001) (66)
Examination of oncogene amplification by genomic DNA microarray in hepatocellular carcinomas: comparison with comparative genomic hybridization analysis. (2001) (66)
Protection against acetaminophen-induced liver injury in vivo by an iron chelator, deferoxamine. (1995) (65)
A change in PBP1 is involved in amoxicillin resistance of clinical isolates of Helicobacter pylori. (2002) (64)
Hepatocellular carcinoma with nonalcoholic steatohepatitis (2004) (64)
Quantitative analysis of liver fibrosis and stellate cell changes in patients with chronic hepatitis C after interferon therapy (1999) (64)
Endoscopic and pathologic features of Epstein-Barr virus-associated gastric carcinoma. (1997) (63)
A multicenter, open-label, dose-ranging study to exploratively evaluate the efficacy, safety, and dose–response of tolvaptan in patients with decompensated liver cirrhosis (2010) (63)
Phase 1 and pharmacological trial of OPB‐31121, a signal transducer and activator of transcription‐3 inhibitor, in patients with advanced hepatocellular carcinoma (2015) (63)
A large-scale, multicentre, double-blind trial of ursodeoxycholic acid in patients with chronic hepatitis C (2007) (63)
Distinct geographic distributions of hepatitis B virus genotypes in patients with acute infection in Japan (2005) (62)
Prognostic factors in patients with advanced hepatocellular carcinoma receiving hepatic arterial infusion chemotherapy (2004) (62)
Increased expression of tumor necrosis factor-α messenger RNA in the intestinal mucosa of inflammatory bowel disease, particularly in patients with disease in the inactive phase (2002) (61)
Effectiveness of local endoscopic resection of rectal carcinoid tumors. (1997) (60)
Essential role of Helicobacter pylori urease in gastric colonization: definite proof using a urease-negative mutant constructed by gene replacement. (1994) (59)
Dose‐finding trial of tolvaptan in liver cirrhosis patients with hepatic edema: A randomized, double‐blind, placebo‐controlled trial (2014) (59)
Usefulness of endoscopic ultrasound-guided fine-needle aspiration biopsy for the diagnosis of pancreatic cancer (2005) (59)
Identification of common or distinct genes related to antitumor activities of a medicinal herb and its major component by oligonucleotide microarray (2003) (59)
Epstein-Barr virus infection of the colon with inflammatory bowel disease (1999) (58)
Endoscopic diagnosis and resection treatment for flat adenoma with severe dysplasia. (1993) (57)
Enhanced interstitial collagenase (matrix metalloproteinase-13) production of Kupffer cell by gadolinium chloride prevents pig serum-induced rat liver fibrosis. (2000) (57)
A multicenter study on the prognosis of fulminant viral hepatitis: Early prediction for liver transplantation (1994) (57)
Endoscopic management of gastric varices using a detachable snare and simultaneous endoscopic sclerotherapy and O‐ring ligation (1999) (56)
Interferon gamma treatment prevents procollagen gene expression without affecting transforming growth factor-beta1 expression in pig serum-induced rat liver fibrosis in vivo. (1998) (55)
FK506 promotes liver regeneration by suppressing natural killer cell activity (1998) (55)
Fibrosis accelerates the development of enzyme‐altered lesions in the rat liver (1998) (54)
In Vitro Anti-Helicobacter pyloriActivities of New Rifamycin Derivatives, KRM-1648 and KRM-1657 (1999) (54)
Expression of hepatocyte growth factor, transforming growth factor α, and transforming growth factor β 1 messenger RNA in various human liver diseases and correlation with hepatocyte proliferation (1996) (54)
Fibroblast growth factor 2 facilitates the differentiation of transplanted bone marrow cells into hepatocytes (2006) (54)
Delineation of the gastric muscularis mucosae and assessment of depth of invasion of early gastric cancer using a 20-megahertz endoscopic ultrasound probe. (1993) (54)
Vascular endothelial growth factor-C expression in human gallbladder cancer and its relationship to lymph node metastasis. (2003) (53)
Anticachectic effects of the natural herb Coptidis rhizoma and berberine on mice bearing colon 26/clone 20 adenocarcinoma (2002) (53)
Analysis of the genotype-determining region of hepatitis A viral RNA in relation to disease severities. (2003) (52)
Efficacy and safety of a 14-day administration of tolvaptan in the treatment of patients with ascites in hepatic oedema (2013) (52)
Prolyl 4-hydroxylase inhibitor (HOE 077) inhibits pig serum-induced rat liver fibrosis by preventing stellate cell activation. (1997) (51)
Interferon therapy for aged patients with chronic hepatitis C: improved survival in patients exhibiting a biochemical response (2004) (49)
Chromosomal imbalances detected by comparative genomic hybridization are associated with outcome of patients with hepatocellular carcinoma (2002) (48)
Increased expression and phosphorylation of liver glutamine synthetase in well‐differentiated hepatocellular carcinoma tissues from patients infected with hepatitis C virus (2006) (48)
Epstein-Barr virus-associated gastric carcinoma and atrophic gastritis. (1999) (47)
Cytochrome P-450 in hyperplastic liver nodules during hepatocarcinogenesis with N-2-fluorenylacetamide in rats. (1976) (47)
Application of ultrasonic probes prior to endoscopic resection of early gastric cancer. (1992) (47)
Cytokine‐dependent anti‐viral role of CD4‐positive T cells in therapeutic vaccination against chronic hepatitis B viral infection (2003) (46)
Nutritional management contributes to improvement in minimal hepatic encephalopathy and quality of life in patients with liver cirrhosis: A preliminary, prospective, open‐label study (2013) (46)
A subpopulation of bone marrow cells depleted by a novel antibody, anti-Liv8, is useful for cell therapy to repair damaged liver. (2004) (46)
Prevention of fibrosis reduces enzyme-altered lesions in the rat liver. (1994) (46)
Detection of K-ras and p53 gene mutations in pancreatic juice for the diagnosis of intraductal papillary mucinous tumors. (1999) (46)
Localization of -fetoprotein in hepatoma tissues by immunofluorescence. (1972) (44)
Lesson from the GFP/CCl4 model--translational research project: the development of cell therapy using autologous bone marrow cells in patients with liver cirrhosis. (2005) (44)
Increased expression of matrix metalloproteinase-7 in invasive early gastric cancer (2003) (44)
Injection sclerotherapy for gastric varices using N-butyl-2-cyanoacrylate and ethanolamine oleate. (1998) (43)
A proteomic profiling of gemcitabine resistance in pancreatic cancer cell lines. (2008) (42)
Hepatitis C virus core protein inhibits deoxycholic acid-mediated apoptosis despite generating mitochondrial reactive oxygen species (2006) (42)
Epstein-Barr virus infection of the colon with inflammatory bowel disease. (1999) (41)
In situ detection of oxidized n-3 polyunsaturated fatty acids in chronic hepatitis C: correlation with hepatic steatosis (2005) (40)
Effect of a late evening snack on the blood glucose level and energy metabolism in patients with liver cirrhosis. (2003) (40)
Cytochrome c is a possible new marker for fulminant hepatitis in humans (2005) (40)
The effect of introduction of universal childhood hepatitis B immunization in South Africa on the prevalence of serologically negative hepatitis B virus infection and the selection of immune escape variants. (2001) (40)
Development of quantitative neuropsychological tests for diagnosis of subclinical hepatic encephalopathy in liver cirrhosis patients and establishment of diagnostic criteria-multicenter collaborative study in Japanese. (2004) (39)
Clinical impact of strip biopsy for early gastric cancer. (2004) (39)
Gadolinium chloride reverses dimethylnitrosamine (DMN)-induced rat liver fibrosis with increased matrix metalloproteinases (MMPs) of Kupffer cells. (2003) (39)
Dexamethasone inhibits induction of liver tumor necrosis factor-alpha mRNA and liver growth induced by lead nitrate and ethylene dibromide. (1994) (38)
Clinical aspects of hepatocellular carcinoma in Japan. (2006) (38)
Herbal medicine Sho-saiko-to (TJ-9) increases expression matrix metalloproteinases (MMPs) with reduced expression of tissue inhibitor of metalloproteinases (TIMPs) in rat stellate cell. (2004) (38)
Hepatocyte proliferation induced in rats by lead nitrate is suppressed by several tumor necrosis factor α inhibitors (1996) (38)
Randomized, open label, multicenter, phase II trial comparing transarterial chemoembolization (TACE) plus sorafenib with TACE alone in patients with hepatocellular carcinoma (HCC): TACTICS trial. (2018) (38)
Survey of survival among patients with hepatitis C virus-related hepatocellular carcinoma treated with peretinoin, an acyclic retinoid, after the completion of a randomized, placebo-controlled trial (2014) (37)
Endoscopic ultrasonography in the diagnosis of esophageal carcinoma, with particular regard to staging it for operability. (1986) (37)
Development of cell therapy using autologous bone marrow cells for liver cirrhosis (2005) (36)
Inhibition of Tumor Necrosis Factor-α Production Retards Liver Regeneration after Partial Hepatectomy in Rats (1997) (36)
Late evening snack and the change of blood glucose level in patients with liver cirrhosis. (2004) (35)
Status and prospects of liver cirrhosis treatment by using bone marrow-derived cells and mesenchymal cells. (2014) (35)
Evaluation of Epstein-Barr virus DNA load in gastric mucosa with chronic atrophic gastritis using a real-time quantitative PCR assay (2003) (35)
Protein level of apolipoprotein E increased in human hepatocellular carcinoma. (2006) (34)
Metaplastic polyp of the colon develops in response to inflammation (1999) (33)
Detection of Genetic Alterations in Pancreatic Cancers by Comparative Genomic Hybridization Coupled with Tissue Microdissection and Degenerate Oligonucleotide Primed Polymerase Chain Reaction (2002) (33)
Safety and effectiveness of sorafenib in Japanese patients with hepatocellular carcinoma in daily medical practice: interim analysis of a prospective postmarketing all-patient surveillance study (2016) (33)
The role of oxidative stress in NASH and fatty liver model. (2005) (33)
Comparative genomic hybridization analysis for pancreatic cancer specimens obtained by endoscopic ultrasonography-guided fine-needle aspiration (2005) (33)
Molecular dissection of a medicinal herb with anti-tumor activity by oligonucleotide microarray. (2005) (33)
GI Cancer High Prevalence of Epstein-Barr Virus in Gastric Remnant Carcinoma after Billroth-II Reconstruction (2002) (32)
Analysis of lymphoid follicles in liver of patients with chronic hepatitis C. (2008) (32)
Clinical effectiveness of bipolar radiofrequency ablation for small liver cancers (2013) (32)
Response criteria of tolvaptan for the treatment of hepatic edema (2018) (31)
Expression of vascular endothelial growth factor correlates with tumor progression in gallbladder cancer. (1998) (31)
Saikosaponin A‐induced cell death of a human hepatoma cell line (HUH‐7): The significance of the “sub‐G1 peak‘ in a DNA histogram (1995) (31)
Detection of proliferating hepatocytes by immunohistochemical staining for proliferating cell nuclear antigen (PCNA) in patients with acute hepatic failure. (2008) (31)
A randomized phase II trial of intra-arterial chemotherapy using SM-11355 (Miriplatin) for hepatocellular carcinoma (2011) (31)
Prolyl 4-hydroxylase inhibitor (HOE 077) prevents TIMP-1 gene expression in rat liver fibrosis (1999) (31)
Carnitine dynamics and their effects on hyperammonemia in cirrhotic Japanese patients (2017) (30)
Novel arterial infusion chemotherapy using cisplatin, 5-fluorouracil, and leucovorin for patients with advanced hepatocellular carcinoma. (2002) (30)
Efficacy and safety of rifaximin in Japanese patients with hepatic encephalopathy: A phase II/III, multicenter, randomized, evaluator‐blinded, active‐controlled trial and a phase III, multicenter, open trial (2018) (30)
Bismuth-free triple therapy for eradicating Helicobacter pylori and reducing the gastric ulcer recurrence rate. (1994) (30)
Genetic Aberrations Detected by Comparative Genomic Hybridization in Biliary Tract Cancers (1999) (30)
Can serum albumin level affect the pharmacological action of tolvaptan in patients with liver cirrhosis? A post hoc analysis of previous clinical trials in Japan (2015) (30)
Laparoscopic ultrasonography. Diagnosis of liver and pancreatic cancer. (1984) (29)
The Fas system is not significantly involved in apoptosis in human hepatocellular carcinoma. (2008) (28)
Timeline for development of autologous bone marrow infusion (ABMi) therapy and perspective for future stem cell therapy (2012) (28)
Esophageal hemangioma: endoscopic diagnosis and treatment. (1994) (28)
Percutaneous radiofrequency ablation with cooled electrodes combined with hepatic arterial balloon occlusion in hepatocellular carcinoma (2005) (28)
Iron Chelator Deferoxamine Reduces Preneoplastic Lesions in Liver Induced by Choline-Deficient L-Amino Acid-Defined Diet in Rats (1999) (28)
Differences in hypervariable region 1 quasispecies of hepatitis C virus between human serum and peripheral blood mononuclear cells. (1996) (27)
Increased rectal wall thickness may predict relapse in ulcerative colitis: a pilot follow-up study by ultrasonographic colonoscopy. (2002) (27)
The Pharmacokinetics and Pharmacodynamics of Tolvaptan in Patients with Liver Cirrhosis with Insufficient Response to Conventional Diuretics: a Multicentre, Double-blind, Parallel-group, Phase III Study (2012) (27)
Efficacy of sucralfate in the prevention of recurrence of peptic ulcer--double blind multicenter study with cimetidine. (1987) (27)
99mTc-HSA-D scintigraphy in the diagnosis of protein-losing gastroenteropathy due to secondary amyloidosis (2005) (27)
Guidelines for the antiviral therapy of hepatitis C virus carriers with normal serum aminotransferase based on platelet counts (2008) (26)
Endoscopic mucosal resection for early esophageal cancer and esophageal dysplasia. (2001) (26)
Herbal medicine Rhei rhizome prevents liver fibrosis in rat liver cirrhosis induced by a choline-deficient L-amino acid-defined diet. (2005) (26)
Interferon retreatment reduces or delays the incidence of hepatocellular carcinoma in patients with chronic hepatitis C (2002) (26)
Neonatal primary hyperparathyroidism in familial hypocalciuric hypercalcemia. (1982) (26)
Therapeutic results of endoscopic variceal ligation for acute bleeding of oesophageal and gastric varices (1997) (25)
Evaluation of new therapy for eradication of H. pylori infection in nude mouse model. (1993) (25)
Comparative genomic hybridization analysis of genetic aberrations associated with development and progression of biliary tract carcinomas (2001) (25)
Efficient detection of hepatocellular carcinoma by a hybrid blood test of epigenetic and classical protein markers. (2011) (24)
Human homologue of maid is a useful marker protein in hepatocarcinogenesis. (2005) (24)
CASE REPORT: Hypoechoic submucosal nodules: A sign of Epstein‐Barr virus‐associated early gastric cancer (1998) (23)
Chemotaxis and motility of Helicobacter pylori in a viscous environment. (1999) (23)
Epstein–Barr virus upregulates phosphorylated heat shock protein 27 kDa in carcinoma cells using the phosphoinositide 3‐kinase/Akt pathway (2008) (23)
Cytoprotection by glycine against hypoxia-induced injury in cultured hepatocytes. (2008) (22)
Expression of Type I Interferon Receptor in Liver and Peripheral Blood Mononuclear Cells in Chronic Hepatitis C Patients (2002) (22)
Interferon therapy as chemoprevention of hepatocarcinogenesis in patients with chronic hepatitis C. (2003) (22)
Relationship of muscle cramps to quality of life and sleep disturbance in patients with chronic liver diseases: A nationwide study (2018) (22)
Evaluation of the Reliability of Chromosomal Imbalances Detected by Combined Use of Universal DNA Amplification and Comparative Genomic Hybridization (2000) (22)
Serial assay of hepatitis C virus RNA in serum for predicting response to interferon-alpha therapy. (1995) (22)
Correlation Between Stellate Cell Activation and Serum Fibrosis Markers in Choline-Deficient l-Amino Acid-Defined Diet-Induced Rat Liver Fibrosis (2000) (22)
Type I interferon receptor and response to interferon therapy in chronic hepatitis C patients: a prospective study (2004) (22)
Effect of peretinoin on recurrence of hepatocellular carcinoma (HCC): Results of a phase II/III randomized placebo-controlled trial. (2010) (21)
Frequent beta-catenin alteration in gallbladder carcinomas. (2003) (20)
Identifying and prioritizing strategies for comprehensive liver cancer control in Asia (2011) (20)
Morphologic studies of the liver cell dysplasia. Cancer (1983) (20)
Leptin receptor-deficient Zucker (fa/fa) rat retards the development of pig serum-induced liver fibrosis with Kupffer cell dysfunction. (2003) (20)
Epstein-barr virus association is rare in esophageal squamous cell carcinoma (2003) (20)
Giant cavernous hepatic hemangioma shrunk by use of sorafenib (2012) (20)
L-cysteine administration prevents liver fibrosis by suppressing hepatic stellate cell proliferation and activation. (2003) (20)
Detection of Ki-ras and p53 gene mutations in tissue and pancreatic juice from pancreatic adenocarcinomas (1998) (19)
Vitamin E and C supplementation prevents decrease of eicosapentaenoic acid in mononuclear cells in chronic hepatitis C patients during combination therapy of interferon alpha-2b and ribavirin. (2006) (19)
417–2α‐Tocopherol and ascorbic acid attenuates the ribavirin‐induced decrease of eicosapentaenoic acid in erythrocyte membrane in chronic hepatitis C patients (2006) (19)
Molecular signature associated with plasticity of bone marrow cell under persistent liver damage by self‐organizing‐map‐based gene expression (2004) (19)
A possible role of hypervariable region 1 quasispecies in escape of hepatitis C virus particles from neutralization (2001) (19)
Rifaximin‐altered gut microbiota components associated with liver/neuropsychological functions in patients with hepatic encephalopathy: An exploratory data analysis of phase II/III clinical trials (2019) (19)
Interferon-gamma down-regulates heat shock protein 27 of pancreatic cancer cells and helps in the cytotoxic effect of gemcitabine. (2009) (18)
Factors predicting progression to cirrhosis and hepatocellular carcinoma in patients with transfusion-associated hepatitis C virus infection. (1999) (18)
Randomized, open label, multicenter, phase II trial of transcatheter arterial chemoembolization (TACE) therapy in combination with sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial. (2018) (18)
Correlation between changes in bodyweight and changes in ascites volume in liver cirrhosis patients with hepatic edema in short‐term diuretic therapy (2014) (18)
Cost-effectiveness of ribavirin plus interferon alpha-2b for either interferon relapsers or non-responders in chronic hepatitis C: a Japanese trial. (2004) (18)
Abducent nerve paralysis during interferon alpha-2a therapy in a case of chronic active hepatitis C. (1994) (18)
Proteomic analysis of serum marker proteins in recipient mice with liver cirrhosis after bone marrow cell transplantation (2006) (18)
Molecular epidemiologic analysis of hepatitis C virus infection in injecting drug users with acute hepatitis C in Japan (2004) (18)
Differences in hypervariable region 1 quasispecies between immune complexed and non-immune complexed hepatitis C virus particles. (1997) (17)
Serial assay of hepatitis C virus RNA in serum for predicting response to interferon-α therapy (2005) (17)
The interplay between gastric cancer cell lines and PBMCs mediated by the CC chemokine RANTES plays an important role in tumor progression. (2005) (17)
Phase I/II study of E7080 (lenvatinib), a multitargeted tyrosine kinase inhibitor, in patients (pts) with advanced hepatocellular carcinoma (HCC): Initial assessment of response rate. (2012) (17)
Ubiquitin is a possible new predictive marker for the recurrence of human hepatocellular carcinoma. (2002) (17)
Heat stress‐induced loss of eukaryotic initiation factor 5A (eIF‐5A) in a human pancreatic cancer cell line, MIA PaCa‐2, analyzed by two‐dimensional gel electrophoresis (2002) (16)
Growth Medium Containing Cyclodextrin and Low Concentration of Horse Serum for Cultivation of Helicobacter pylori (1994) (16)
Hepatic fas antigen expression before and after interferon therapy in patients with chronic hepatitis C (1996) (16)
p53 Mutations in Two Patients with Intraductal Papillary Adenoma of the Pancreas (1996) (16)
Upregulation of the truncated basic hair keratin 1(hHb1‐ΔN) in carcinoma cells by Epstein‐Barr virus (EBV) (2003) (16)
Phylogenetic analysis of hepatitis A virus in sera from patients with hepatitis A of various severities (2009) (16)
Dieulafoy's lesion of the esophagus correctly diagnosed and successfully treated by the endoscopic injection of N-butyl-2-cyanoacrylate. (2004) (16)
Carcino-fetal proteins and gastric cancer (1977) (16)
Preventive effect of cyclosporin A on experimentally induced acute liver injury in rats. (2008) (16)
Role of Epidermal Growth Factor in Protection and Repair of Gastric Mucosal Injury (1991) (15)
Glycine-to-arginine substitution at codon 145 of HBsAg in two infants Born to hepatitis B e antigen-positive carrier (1995) (15)
Numerical Aberrations of Chromosomes 16, 17, and 18 in Hepatocellular Carcinoma (A FISH and FCM Analysis of 20 Cases) (2004) (15)
Ubiquitin and hepatocellular carcinoma (2002) (15)
Upregulation of LMP1 Expression by Histone Deacetylase Inhibitors in an EBV Carrying NPC Cell Line (2004) (15)
Antioxidant, N-acetyl-L-cysteine inhibits the expression of the collagen alpha2 (I) promoter in the activated human hepatic stellate cell line in the absence as well as the presence of transforming growth factor-beta. (2002) (15)
Immunohistochemical study of Fas antigen in liver of patients with chronic hepatitis and autoimmune liver disease (1995) (14)
Endoscopic hemostasis for bleeding peptic ulcer using a hemostatic clip or pure ethanol injection. (2000) (14)
Recent clinical studies on lipo-PGE1 and lipo-PGI2: PGE1 and PGI2 incorporated in lipid microspheres, for targeted delivery (1994) (14)
Endoscopic injection sclerotherapy with ligation versus endoscopic injection sclerotherapy alone in the management of esophageal varices: a prospective randomized trial. (2000) (14)
Experience with photodynamic therapy (endoscopic laser therapy) for the treatment of early gastric cancer. (2001) (14)
The efficacy and safety of terlipressin and albumin in patients with type 1 hepatorenal syndrome: a multicenter, open-label, explorative study (2012) (14)
A new cell therapy using bone marrow cells to repair damaged liver (2002) (14)
The pilot experience of immunotherapy-combined photodynamic therapy for advanced gastric cancer in elderly patients (2002) (14)
Plasma level of a 5-fluorouracil metabolite, fluoro-beta-alanine correlates with dihydropyrimidine dehydrogenase activity of peripheral blood mononuclear cells in 5-fluorouracil treated patients. (2006) (13)
Role of superoxide dismutase in mechanism of diethyldithiocarbamate‐induced gastric antral ulcer in rats: Protective effect of prostaglandin, cimetidine and pirenzepine (1993) (13)
Prognostic value and interobserver agreement of endoscopic ultrasonography for superficial squamous cell carcinoma of the esophagus (2003) (13)
Clinical significance of measuring blood coagulation factor XIIIA regularly and continuously in patients with Crohn’s disease (2006) (13)
Bleeding Meckel's diverticulum in an adult. (2001) (12)
Timing of interferon therapy and sources of infection in patients with acute hepatitis C. (2006) (12)
Does IL-6 regulate liver fibrosis / cirrhosis directly and indirectly? (2000) (12)
Arterial infusion chemotherapy using cisplatin, 5-fluorouracil, and isovorin for patients with advanced hepatocellular carcinoma, pilot study: Is a high dose of the biochemical modulator effective? (2003) (12)
Evaluation of Peptic Ulcer Healing with a Highly Magnifying Endoscope: Potential Prognostic and Therapeutic Implications (1991) (12)
Two‐dimensional zymography for analysis of proteolytic enzymes in human pure pancreatic juice (1998) (12)
[Focal autoimmune pancreatitis which discovered for formation of a large pancreatic pseudocyst]. (2003) (12)
Ultrastructural Study of Development of Hepatic Necrosis Induced by TNF-α and D-Galactosamine (1998) (12)
An antigen specific to hyperplastic liver nodules defined with monoclonal antibody: a new marker for preneoplastic cells in rat chemical hepatocarcinogenesis. (1988) (12)
Up-regulation of 42 kDa tubulin alpha-6 chain fragment in well-differentiated hepatocellular carcinoma tissues from patients infected with hepatitis C virus. (2011) (11)
Lipid composition and fatty acid analysis of Helicobacter pylori. (1995) (11)
Fulminant hepatitis complicated by small intestine infection and massive hemorrhage (1998) (11)
Constrained genomic and conformational variability of the hypervariable region 1 of hepatitis C virus in chronically infected patients (2002) (11)
Lipid analysis of Helicobacter pylori. (1993) (10)
Effects of secretin on TCDCA- or TDCA-induced cholestatic liver injury in the rat. (2002) (10)
Clinical benefit of peretinoin for the suppression of hepatocellular carcinoma (HCC) recurrence in patients with Child-Pugh grade A (CP-A) and small tumor: A subgroup analysis in a phase II/III randomized, placebo-controlled trial. (2011) (10)
Importance of inhibitor of DNA binding/differentiation 2 in hepatic stellate cell differentiation and proliferation (2007) (10)
Glucose utilization after administration of glucose in patients with cirrhosis. (1999) (10)
Hepatic expression of type I interferon receptor for predicting response to interferon therapy in chronic hepatitis C patients: a comparison of immunohistochemical method vs. competitive polymerase chain reaction assay. (2003) (10)
Clinical interpretation of the histological typing of gastric cancer using endoscopic forceps biopsy. (2004) (10)
Association between the interleukin-1 receptor antagonist polymorphism and ulcerative colitis with younger age at diagnosis. (2003) (10)
Transmission of Helicobacter pylori from Challenged to Nonchallenged Nude Mice Kept in a Single Cage (2000) (10)
Three‐dimensional endoscopic ultrasonography of lesions of the upper gastrointestinal tract using a radial‐linear switchable thin ultrasound probe (1999) (9)
Inhibition of tumor necrosis factor-alpha production retards liver regeneration after partial hepatectomy in rats. (1997) (9)
Effects of the elevation of serum bile acids on gastric mucosal damage (1999) (9)
Ranitidine: a pilot study in Japan. (1981) (9)
Clinical characteristics of patients with chronic hepatitis C showing biochemical remission, without hepatitis C virus eradication, as a result of interferon therapy. The Osaka Liver Disease Study Group. (2000) (9)
Clinical use of glucagon and insulin in therapy of fulminant hepatic failure (1979) (9)
Clinical features of liver cirrhosis patients with muscle cramping: a multicenter study. (2019) (9)
Antitumor effect of vesnarinone on human hepatocellular carcinoma cell lines. (1999) (9)
Role of oxygen-derived free radicals in the mechanism of cysteamine-induced duodenal ulcer in rats. (1994) (9)
Validating a Markov Model of Treatment for Hepatitis C Virus-related Hepatocellular Carcinoma (2008) (8)
Localized amyloidosis of the stomach. (1991) (8)
Relationship between matrix metalloproteinase-7 and pit pattern in early stage colorectal cancer. (2004) (8)
Endosonographic diagnosis of metastatic lymph nodes in gastric carcinoma. (1992) (8)
Studies of alpha-napthylisothiocyanate-induced hepatic disturbance. (1980) (8)
New prolyl 4‐hydroxylase inhibitor reduces procollagen gene expression and enzyme‐altered lesions in rat liver cirrhosis (1995) (8)
Prolyl 4-hydroxylase inhibitor is more effective for the inhibition of proliferation than for inhibition of collagen synthesis of rat hepatic stellate cells. (2002) (8)
Interferon γ- but not α-treatment prevents fibrosis by inhibiting procollagen and tissue inhibitor of metalloproteinase-1 gene expression in pig serum-induced rat liver fibrosis in vivo (1998) (8)
Characteristics of the cell proliferation profile of activated rat hepatic stellate cells in vitro in contrast to their fibrogenesis activity (2001) (8)
Immunohistological study to determine the presence of pericryptal myofibroblasts and basement membrane in colorectal epithelial tumors (1999) (8)
Hepatitis B virus carrier status linked to autoimmune hepatitis. (1996) (8)
Inhibitory effects of polyprenoic acid (E5166) on production and secretion of alpha-fetoprotein and on cell kinetics in human hepatoma cells. (1986) (8)
Preliminary experience with a gastrointestinal endoscope using a white light-emitting diode. (2006) (7)
D-Penicillamine improved laparoscopic and histological findings of the liver in a patient with Wilson’s disease: 3-year follow-up after diagnosis of Coombs-negative hemolytic anemia of Wilson’s disease (2005) (7)
Final Results of TACTICS: A Randomized, Prospective Trial Comparing Transarterial Chemoembolization Plus Sorafenib to Transarterial Chemoembolization Alone in Patients with Unresectable Hepatocellular Carcinoma (2022) (7)
Protein degradation in human pure pancreatic juice analyzed by two‐dimensional gel electrophoresis (1996) (7)
Alpha-tocopherol [corrected] and ascorbic acid attenuates the ribavirin [corrected] induced decrease of eicosapentaenoic acid in erythrocyte membrane in chronic hepatitis C patients. (2006) (7)
Relationship between molecular markers and endoscopic findings in laterally spreading tumors (2007) (7)
[Detection of TT virus in hemodialysis patients]. (1999) (7)
Preventive Effect of FK 506 (Tacrolimus Hydrate) on Experimentally Induced Acute Liver Injury in Rats (2000) (7)
Rupture of peritoneal metastatic tumor that developed due to needle-tract implantation of hepatocellular carcinoma (2005) (7)
Proposal of Stroop test cut‐off values as screening for neuropsychological impairments in cirrhosis: A Japanese multicenter study (2021) (7)
[Definition of the adaptation of endoscopic surgery for early gastric cancer. Special examination on the relationship between the histological differentiation of the intramucosal gastric cancer and the lymph node metastasis]. (1989) (7)
Th1 down-regulation at the single-lymphocyte level in HCV-related liver cirrhosis and the effect of TGF-beta on Th1 response: possible implications for the development of hepatoma. (2002) (7)
Use of entecavir to prevent hepatitis B virus reactivation during cytotoxic chemotherapy for solid malignancy (2009) (7)
Endoscopic findings potentially predictive of gastric cancer in borderline lesions diagnosed by forceps biopsy. (2005) (7)
Simple and sensitive detection of K-ras gene mutations in human pancreatic cancers by nonradioisotopic single-strand conformation polymorphism analysis (2005) (7)
Calcium Concentration and Artificial Precipitates in Human Pancreatic Juice (2000) (7)
Change of alpha-fetoprotein content during cell cycle of human hepatoma cells in vitro: flow cytometric analysis. (1986) (7)
Some biochemical properties of the preneoplastic antigen in rat liver hyperplastic nodules. (1982) (7)
Analysis of hepatitis A virus protein 2B in sera of hepatitis A of various severities (2007) (7)
Ultrastructural study of development of hepatic necrosis induced by TNF-alpha and D-galactosamine. (1998) (7)
[Th1/Th2 imbalance in HCV-related liver cirrhosis]. (2001) (6)
GB virus C/hepatitis G viremia and antibody response to the E2 protein of hepatitis G virus in hemodialysis patients. (2000) (6)
[Evaluation of MRCP compared to ERCP in the diagnosis of biliary and pancreatic duct]. (1998) (6)
A multi-centre double-blind controlled trial of glucagon and insulin therapy for severe acute hepatitis (1989) (6)
[Early gastric cancer]. (1996) (6)
Percutaneous hot water injection therapy (PHoT) for treatment of hepatocellular carcinoma: a comparision with percutaneous ethanol injection therapy (PEIT) (1995) (6)
Does cytoplasmic cyclin D1 regulate the cell cycle directly? (1999) (6)
Hepatitis C virus infection upregulates expression of the type I interferon receptor in human peripheral blood mononuclear cells. (2003) (6)
FUNDAMENTAL STUDIES ON LUGOL STAINING METHOD OF ESOPHAGEAL CARCINOMAS (1981) (6)
Evaluation of a new bismuth-free triple therapy in nude mice and humans. (1995) (6)
Mucin and differentiation in Epstein-Barr virus-associated gastric carcinoma. (2005) (6)
A novel in vitro effect of the mucosal protective agent sofalcone – inhibition of chemotactic motility in Helicobacter pylori (2000) (6)
Gastrointestinal tumors, non-colorectal (2012) (6)
Study on the mechanism of inhibition of chemical hepatocarcinogenesis by polyprenoic acid. (1985) (5)
Use of bone marrow cells for the development of cellular therapy in liver diseases. (2005) (5)
A new therapeutic trial of secretin in the treatment of intrahepatic cholestasis (1989) (5)
Percutaneous hot water injection and microwave coagulation therapy for small hepatocellular carcinoma (1997) (5)
Effect of a hot water extract of Agaricus blazei fruiting bodies(CJ-01) on the intracellular cytokines level in a patient with bronchitis (2002) (5)
Protection by glycine against chemical ischemia produced by cyanide in cultured hepatocytes (1996) (5)
[A possible role of human leukocyte antigen(HLA) typing for predicting response to interferon therapy in chronic hepatitis C]. (2001) (5)
HBV-related fulminant hepatic failure: successful intensive medical therapy in a candidate for liver transplantation (2001) (5)
In-Vitro Endosonographic Appearance of Muscularis Mucosae of the Esophagus (1997) (5)
Genetic analysis of hepatitis A virus protein 2C in sera from patients with fulminant and self-limited hepatitis A. (2007) (5)
Proposal for new sleep disorder criteria in patients with chronic liver disease: Influence of liver‐related complications (2021) (5)
Effects on liver functions of gastric variceal therapy by endoscopic ligation using a detachable snare and sclerotherapy with O-ring ligation. (2002) (5)
Clinical evaluation of glucagon and insulin in therapy of fulminant hepatitis (1987) (5)
Pyloric stenosis due to Crohn's disease (1998) (5)
A Case of CholangioDuodenal Fistula Formation After Metallic Stenting for Malignant Biliary Stricture (1995) (5)
Antithrombin III concentrate in the treatment of fulminant hepatic failure (1988) (5)
GASTRIC MUCOSA IN PATIENTS WITH REFLUX ESOPHAGITIS (1981) (4)
A case of primary hepatocellular carcinoma in childhood with HBs-antigenemia (1977) (4)
[Immunohistological study on the expression of proliferating cell nuclear antigen (PCNA/cyclin) in human colorectal lesions]. (1992) (4)
Polymorphisms of the IL-1beta and IL-1beta-inducible genes in ulcerative colitis. (2002) (4)
Secretin prevents taurocholate-induced intrahepatic cholestasis in the rat. (1994) (4)
Clinicopathological studies of the Dubin-Johnson syndrome complicated with chronic hepatitis (1982) (4)
Applied nutritional investigation Vitamin E and C supplementation prevents decrease of eicosapentaenoic acid in mononuclear cells in chronic hepatitis C patients during combination therapy of interferon -2b and ribavirin (2006) (4)
Distribution of alpha-fetoprotein-producing cells and proliferating cells in human hepatoma cells transplanted into athymic mice. (1987) (4)
Risk Factors for Hepatocellular Carcinoma Among Chronic Hepatitis C Patients Treated with Interferon (1999) (4)
First international symposium of current issues for nationwide survey of primary liver cancer in Korea, Taiwan and Japan. (2007) (4)
Clinical efficacy of combination therapy with ME3738 and pegylated interferon‐alpha‐2a in patients with hepatitis C virus genotype 1 (2014) (4)
Clinical Experience with Prototype Pancreatoscopes (1990) (4)
Functional differences between activated and normal rat liver macrophages: LPS uptake capacity by flow cytometric analysis in contrast with TNF-alpha release. (1995) (4)
Clinical evaluation of intramuscular administration of natural interferon-gamma in the treatment of chronic hepatitis B. (1995) (3)
Peritoneoscopic findings and liver function in chronic liver disease. (1980) (3)
[A case of fulminant hepatitis developing in a HBsAG carrier after chemotherapy of malignant lymphoma]. (1984) (3)
Liver fibrosis and carcinogenesis (2000) (3)
Lipid composition and fatty acid analysis ofHelicobacter pylori (1995) (3)
The Potential of Interferons in Malignant Disease (2012) (3)
Glucagon in digestive endoscopy — its usefulness for premedication (1987) (3)
Long-term survived cases of hepatocellular carcinoma without chemotherapy (1979) (3)
Comparison of Various Precipitin Tests in the Detection of α-Fetoprotein in Serum (1972) (3)
[Ultrasound image of muscularis mucosae of the stomach]. (1991) (3)
[A case of AFP producing pancreatic acinar cell carcinoma diagnosed by EUS FNA and treated by intraarterial injection chemotherapy]. (2004) (3)
[Th1/Th2 balance in HCV-related liver cirrhosis and the effect of TGF-beta on Th1 response: possible implications for the development of hepatoma]. (2004) (3)
Loss of Inhibitory Growth Regulation by TGF-β1 in Preneoplastic Lesions in Rat Liver (2000) (3)
Functional differences between activated and normal rat liver macrophages: LPS uptake capacity by flow cytometric analysis in contrast with TNF-α release (2008) (3)
Increased expression of heat shock protein-binding protein 1 and heat shock protein 70 in human hepatocellular carcinoma tissues. (2008) (3)
Association between serum albumin and cognitive dysfunction in hepatic encephalopathy: An exploratory data analysis (2020) (3)
Curious manifestations in cavernous hemangioma of the liver. (1984) (3)
A CASE OF MULTIPLE HAMARTOMAS OF THE STOMACH MIMICKING A SUBMUCOSAL TOMOR (1993) (3)
[A case of primary hepatic lymphoma]. (1991) (3)
Progress in Hepatocellular Carcinoma Treatment (2012) (3)
Mass Spectrometric Study of Protein Molecular Diversity-Posttranslational Modification of Liver Glutamine Synthetase in Hepatoma- (2003) (3)
A Study on Interaction of the Therapeutic Agents for Hepatitis to the Damaged Liver Cells (1975) (3)
High MDM2 mRNA expression in hepatoblastoma cell-lines (1995) (3)
Detection of hepatitis B virus DNA in liver by polymerase chain reaction for the diagnosis of fulminant hepatitis B (1998) (3)
Complication of laparoscopy in Japan (1979) (3)
Development of the White Light-Emitting Diode-Illuminated Digestive Endoscope (2004) (3)
A case of colonic actinomycosis difficult to distinguish from advanced colonic carcinoma. (1995) (3)
The Role of Copper and Zinc as Pathogenic Factors in Liver Disease (1990) (3)
DEVELOPMENT OF ULTRASONIC LAPAROSCOPE (1982) (3)
Clinical relevance of increased serum preneoplastic antigen in hepatitis C-related hepatocellular carcinoma (2020) (2)
Two cases of acute liver injury caused by ingesting small dose of acetoaminophen. (1985) (2)
Utilization of solubility of alpha-fetoprotein in 34 percent ammonium sulfate in the preparation of antiserum and its test. (1971) (2)
Clinical evaluation of glucagon—insulin therapy for acute hepatitis severe form (1987) (2)
Macroscopic and stereomicroscopic diagnosis of superficial flat-type early carcinomas of the gallbladder (1997) (2)
Endoscopic ultrasonography. (1986) (2)
Endoscopic Ultrasonography and Endoscopy for Staging of Depth of Invasion in Early Gastric Cancer: A Prospective Blind Study (1998) (2)
[Polypectomy and strip biopsy]. (1991) (2)
Clinical evaluation of chronic liver diseases induced by different hepatitis C virus genotype in Japan, focused on the difference between genotypes III/2a and IV/2b (1999) (2)
Clinicopathologic features of early hepatocellular carcinoma. (1996) (2)
The effects of diuretic use and the presence of ascites on muscle cramps in patients with cirrhosis: a nationwide study (2020) (2)
[A case report of internal hernia through an abnormal defect in the broad ligament of the uterus]. (2010) (2)
Evaluation of Laparoscopic Findings in Chronic Hepatitis C (1991) (2)
[An autopsy case of hepatocellular carcinoma with pleural metastasis]. (2004) (2)
[Sequential observations on development of esophageal carcinoma in Donryu rats induced by N-butyl-N-nitroso urethane (author's transl]. (1981) (2)
Nutritional Therapy in Patients with Liver Cirrhosis (2005) (2)
Prevention of Hepatocarcinogenesis by Fibrosuppression (2000) (2)
NASH and Nutritional Therapy (2005) (2)
A case of gastric carcinoma whose serum was positive for alpha-fetoprotein, variant alkaline phosphatase and CEA (author's transl). (1978) (2)
Early lesions and development of primary hepatocellular carcinoma in man—association with hepatitis B viral infection (2007) (2)
Correlation Between Relative Number of Circulating Low-Density Hepatitis C Virus Particles and Disease Activity in Patients with Chronic Hepatitis C (1997) (2)
Mechanism of action of ethanolamine oleate used in injection sclerotherapy with special emphasis on the bronze varices. (1989) (2)
Immunohistological detection of PCNA/cyclin in paraffin-embedded liver tissue (1993) (2)
Electronic endoscopy: Its present and future (1989) (2)
Unique Fatty Acids of Helicobacter pylori are Methoxy Fatty Acids. (1993) (2)
Evaluation of methylene blue and triple therapy for eradication of Helicobacter pylori infection in the nude mouse model (1993) (2)
[Restriction endonuclease (NotI) analysis of chromosomal DNA of Helicobacter pylori by PFGE]. (1993) (2)
680 CLINICAL CHARACTERISTICS, TREATMENT AND PROGNOSIS OF NON-B NON-C HEPATOCELLULAR CARCINOMA: A LARGE RETROSPECTIVE MULTICENTER COHORT STUDY (2013) (2)
[Diagnosis of gastro esophageal reflux disease and reflux esophagitis by using the questionnaire]. (2004) (1)
A Case of Multiple Early Gastric Cancer Treated Endoscopically in the Reconstructed Stomach after Esophagectomy (2004) (1)
A CASE OF METACHRONOUS MULTIPLE PRIMARY CANCER OF THE GALLBLADDER CARCINOMA AND THE EARLY BILE DUCT CARCINOMA (1996) (1)
Chemotherapy of liver carcinoma (II) (1979) (1)
Induction to Granulocytic Differentiation of Human Promyelocytic Leukemia Cells （HL－6０） by Polyprenoic Acid （E5166） (1986) (1)
Stem Cell and Liver Regeneration (2004) (1)
Lower levels of serum albumin are associated with impairment of cognitive function in cirrhotic patients with early-stage hepatic encephalopathy: An exploratory data analysis of phase II/III clinical trials of rifaximin in Japan (2020) (1)
Present status of immunotherapy of hepatocellular carcinoma (1992) (1)
Helicobacter pylori infection prevents nocturnal gastric acid breakthrough. (2006) (1)
The clinical meaning of mucin phenotype and Epstein-Barr virus infection in gastric cancer. (2008) (1)
[A case of HBV carrier with acute hepatitis type B developed after initial infection in adulthood]. (1992) (1)
[From viral hepatitis to hepatocellular carcinoma]. (2001) (1)
Evaluation of power Doppler imaging in the management of small liver cancer (1998) (1)
HCV and Related Liver Diseases (1999) (1)
Clinical significance of glucagon test, evaluating reserved liver function (1980) (1)
Therapy for Viral Hepatitis and Prevention of Hepatocellular Carcinoma (2004) (1)
Polymorphisms of the IL-1β and IL-1β-inducible genes in ulcerative colitis (2002) (1)
Marked hyperlipidemia and intrahepatic cholestasis-case report- (1980) (1)
Anal Dilatation for Fissure-in-ano (2006) (1)
A Case of Metastatic Cancer of the Rectum Originated from Gastric Cancer Type 4 Chanced by the Symptom of Narrowing of the Stool (2004) (1)
Expression of Sialylparagloboside in a Case of Liposarcoma: Aberrant Glycosylation in Tumors Arising in Adipose Tissues (1995) (1)
Clinical investigations on the levels of serum TNF-.ALPHA. in the patients with acute liver injury. (1992) (1)
INVESTIGATION ON THE EFFICACY USING A MINIATURE ULTRASONIC PROBE (1991) (1)
Original ContributionsQuantitative analysis of liver fibrosis and stellate cell changes in patients with chronic hepatitis C after interferon therapy (1999) (1)
Characteristics of gastric mucus in elderly patients with gastric ulcers. (2001) (1)
[Purification of a new glutathione S-transferase from rat liver cytosol and its significance during hepatocarcinogenesis]. (1984) (1)
Erratum to: Clinical effectiveness of bipolar radiofrequency ablation for small liver cancers (2013) (1)
P572 INSULIN USE IS RELATED TO THE DEVELOPMENT OF HEPATOCELLULAR CARCINOMA AT YOUNGER AGE WITH NON-VIRAL ETIOLOGY (2014) (1)
Clinical significance of serum level of thrombomodulin in several liver diseases: especially in acute liver failure. (1992) (1)
Protective effect of deferoxamine for acetaminophen induced liver injury (1992) (1)
Endoscopic Diagnosis in the Era of Molecular Biology (1995) (1)
A CASE OF AGENESIS OF THE DORSAL PANCREAS. (1979) (1)
The Usefulness of the Athens Insomnia Scale for Evaluating Sleep Disturbance in Patients with Chronic Liver Disease Comparing with Pittsburgh Sleep Quality Index and Epworth Sleepiness Scale (2022) (1)
Growth, Proliferation, and Apoptosis in Hepatocytes (2002) (1)
A phase I, open-label, nonrandomized trial of OPB-31121, a STAT3 inhibitor, in patients with advanced hepatocellular carcinoma (HCC). (2014) (1)
Screening of hepatocellular cancer: Japanese strategy (2007) (1)
[A case of gastric cancer with multiple liver metastases responding completely to TS-1]. (2004) (1)
ENDOSCOPIC ULTRASONOGRAPHIC (EUS) FINDINGS IN PRIMARY SCLEROSING CHOLANGITIS (PSC) AND INTRAMURAL COMMON BILE DUCT CANCER (1990) (1)
Relationship of serum 2.5 oligoadenylate synthetase activity during interferon therapy to pretreatment levels or genotypes of serum HCV-RNA (1994) (1)
Heat stress-induced loss of eukaryotic initiation factor 5A (eIF-5A) in a human pancreatic cancer cell line, MIA PaCa-2, analyzed by two-dimensional gel electrophoresis. (2002) (1)
“Rebound” phenomenon of hepatitis C viremia after interferon therapy in “relapsed” patients with chronic hepatitis C (1995) (1)
Endoscopic resection of early duodenal cancer using a strip biopsy technique (2000) (1)
Endoscopic Findings of Primary Sclerosing Cholangitis—‐Report of a Case— (1992) (1)
Changes of depolymerized and polymerized tubulin proteins in the liver after taurocholic acid administration with or without colchicine pretreatment and cholestasis due to cytochalasin B and bile duct ligation in rats (1996) (1)
Phase I/II Trial of Lenvatinib (E7080), A Multi-Targeted Tyrosine Kinase Inhibitor, in Patients (PTS) with advanced Hepatocellular Carcinoma (HCC) (2012) (1)
3 cases of HBsAg carrier with fulminant liver failure induced by withdrawal of steroid therapy. (1988) (1)
A CASE OF GASTRIC PLASMACYTOMA SHOWN ENDOSCOPICALLY WHITISH GRANULAR APPEARANCE (1996) (1)
[Metastasized leiomyoblastoma of the stomach. Clinicopathological study of a typical case (author's transl)]. (1978) (1)
[A case of primary acquired agammaglobulinemia accompanied with nodular lymphoid hyperplasia of the gastrointestinal tract from duodenum to half of jejunum--reviewing Japanese literature, reported 40 cases (author's transl)]. (1979) (1)
Sequential Analysis of Drug Metabolizing Enzymes During Initiation and Promotion in Chemical Hepatocarcinogenesis (1983) (1)
Advance of endoscopy. (1981) (1)
[A case of hepato-cellular-carcinoma after recovery from shock state with cardiac and respiratory arrest caused by administration of larger dose of ICG]. (1990) (1)
Wild-typep53 gene-induced morphological changes and growth suppression in hepatoma cells (1997) (1)
Immunohistological detection of proliferating cells using anti-PCNA monoclonal antibody in paraffin-embedded liver needle-biopsied specimens. (1991) (1)
History of endoscopic diagnosis and treatment (1990) (1)
Detection of serum hepatitis B, C, and D viral nucleic acids and its implications in hepatocellular carcinoma. (1998) (1)
STATISTICAL STUDY ON RISK FACTGRS PREDICTING UNSUCCESSFUL ENDOSCOPIC H:E:MOSTASIS OF BLEEDING GASTRIC ULCEIR (1997) (0)
[Influence of H2-receptor antagonists to liver blood flow in rat]. (1985) (0)
7th Meeting of the European Association for the Study of the Liver (1972) (0)
[My journey to explore the reproductive medicine for intractable liver disease]. (2005) (0)
[Therapeutic effect of secretin on intrahepatic cholestasis. A case report]. (1988) (0)
Symposium (I): Immuno-biochemical diagnosis of hepatoma (1976) (0)
Proceedings of the 27th Annual Meeting Matsuyama, Japan, November 7–9, 1985 (1986) (0)
[Molecular analysis of hepatitis C virus in pathogenesis of chronic hepatitis C]. (2004) (0)
[Therapy of chronic non-active hepatitis]. (1994) (0)
THE LAPAROSCOPIC STUDY OF THE LIVER SURFACE OF RAT DURING HEPATOCARCINOGENESIS WITH 3'-METHYL-4-DIMETHYLAMINOAZOBENZENE (1981) (0)
Ulcerative Colitis complicated by a Leaked Colojejunal Fistula: Report of a Case (1999) (0)
Hepatitis C virus-induced reactive oxygen species cause iron accumulation in mice by reducing hepcidin transcription (2007) (0)
Endoscopic resection of early duodenal cancer using a strip biopsy technique. (2000) (0)
Treatment of Hepatocellular Carcinoma by Inter-arterial Infusion with Mitomycin C (1981) (0)
Abstracts of selected papers presented at the 29th annual meeting of the japanese society of gastroenterology (1988) (0)
MORPHOLOGICAL AND FUNCTIONAL STUDY OF THE ATROPHIC BORDER IN CHRONIC GASTRITIS (2) (1978) (0)
Erratum to: A multicenter, open-label, dose-ranging study to exploratively evaluate the efficacy, safety, and dose–response of tolvaptan in patients with decompensated liver cirrhosis (2010) (0)
The efficacy and safety of terlipressin and albumin in patients with type 1 hepatorenal syndrome: a multicenter, open-label, explorative study Yoshiyuki NaraharaHidenori KanazawaChoitsu SakamotoHitoshi Maruyama • Osamu YokosukaSatoshi MochidaMasahito UemuraHiroshi FukuiYasukiyo Sumino • (2011) (0)
Hiroaki Takeuchi , in a Viscous Environment pylori Helicobacter Chemotactic Motility of Urease Plays an Important (1998) (0)
[Peripheral lymphocyte examination--evaluation and application of the tests in the diagnosis of liver disease]. (1986) (0)
[Treatment of hepatic diseases with bone marrow stem cell transplantation]. (2005) (0)
Direct evidence of eNOS expression and NO production in hepatic stellate cells (2004) (0)
α-Fetnprotein Containing Cells in Early Stages during Hepatocarcinogensis in Rats Fed 2－Acetylaminofluorene (1984) (0)
NEW TRIAL FOR DIAGNOSIS OF INTRAHEPATIC LESIONS BY USING EPCG (1977) (0)
[Nutritional treatment of hepatocellular carcinoma]. (1992) (0)
SPECIAL REVIEW SERIES: New ultrastructural discoveries in the pathophysiology of liver diseases (2005) (0)
ENDOSCOPIC STUDY ON THE GASTRO-DUODENAL EPITHELIAR BORDER (THE SECOND REPORT) (1981) (0)
Chemotaxis of Helicobacter pylori: a urease-independent response. (1998) (0)
[Hepatic regeneration factor in fulminent hepatitis and its dynamic changes]. (1982) (0)
A case of metastasis to the pancreas from malignant fibrous histiocytoma of the bone which was difficult in differentiation from pancreatic cancer (1991) (0)
First Digestive Disease Week of Japan and Thirty-Fifth Annual Autumn Meeting of the Japanese Society of Gastroenterology September 20–24, 1993, Kobe, Japan (2007) (0)
Abstracts of Selected Papers Presented at the 77th General Meeting of the Japanese Society of Gastroenterology (1992) (0)
A case of Primary Biliary Cirrhosis with Benefucial Effect of Secrerin in the Treatment of Jaundice - with a Study of Secretin Induced Choloresis in Man- (1994) (0)
A blind comparison of the e V ectiveness of endoscopic ultrasonography and endoscopy in staging early gastric cancer (1999) (0)
ELECTROCARDIOGRAPHIC CHANGES DURING PERITONEOSCOPY UNDER LOCAL ANESTHESIA (1978) (0)
Multicenter study of hepatocellular carcinoma of more than ten years survival in Chugoku district (2005) (0)
[Clinical aspects of TTV infection]. (2004) (0)
[Management of ambulatory chemotherapy in a hospital]. (2005) (0)
[Case of ovarian tumor with positive reaction for alpha-fetoprotein]. (1971) (0)
Identification of the drug resistance related protein and possible application for the pancreatic cancer chemotherapy. (2008) (0)
Effects of serum from patients with fulminant hepatic failure on bile flow. (1986) (0)
A significans of hyperplastic liver nodules as the precancerous lesion analyzed from the view point of cell growth (0)
[Early gastric cancer staging by radiology, endoscopy, trans-endoscopic ultrasonography and its anatomo-pathological correlation]. (1994) (0)
[Care of the newborn infant]. (1968) (0)
A CASE OF RESECTED SMALL HEPATOCELLULAR CARCINOMA DEFINATELY DIAGNOSED BY PERITONEOSCOPY (1980) (0)
Forefront of hepatoma medical care. (2005) (0)
A Case Report of Seuretin Therapy for Primary Sclerosing Cholangitis (1994) (0)
A Relationship between Differentiation and Phenotypic Expression in Cultured Epithelial like Cell from Rat Liver. (1976) (0)
Chemoprevention of Hepatocellular Carcinoma: Summary of a Satellite Symposium (1994) (0)
Two Cases of Proton Pump Inhibitor (PPI)-resistant Gastric Ulcers Caused by Gastric Empting Disturbance (2005) (0)
Effects of secretin on bile production in two kinds of cholestatic models by choledocho-caval fistula and bile duct ligation in rats (1992) (0)
Thirty-second annual meeting of the Japanese Society of Gastroenterology (2007) (0)
Anti-Fibrotic Agent Reduces Enzyme-Altered Lesions and Neoplasms in the Rat Liver (1999) (0)
FINE GASTRIC MUCOSAL PATTERN ON GASTRIC LESION (1980) (0)
[Type I IFN receptor]. (2001) (0)
CLINICAL EVALUATION OF A NEW DESIGNED THIN ECHO-VIDEOENDOSCOPE (1999) (0)
624 STAKEHOLDER INVOLVEMENT IN PRIORITY SETTING OF STRATEGIES TO IMPROVE HEPATOCELLULAR CARCINOMA POLICY IN ASIA (2011) (0)
EFFECT OF MAPKS ACTIVITY ON MMP-2/TIMPS EXPRESSION IN HSC (2001) (0)
Combination Therapy for Intestinal Amebiasis Using an Anti‐amebic Drug and Total Parenteral Nutrition —Report of Two Cases— (1993) (0)
DEVELOPMENT OF A SMALL DIAMETER LAPAROSCOPE AND ITS APPLICATION (1984) (0)
[Study on epoxide hydrolase in rat hyperplastic nodule and hepatoma during chemical hepatocarcinogenesis induced by 2-acetylaminofluorene (author's transl)]. (1982) (0)
Safety and Pharmacokinetics of Lenvatinib in Patients with Advanced Hepatocellular (2015) (0)
First Digestive Disease Week of Japan and Thirty-Fifth Annual Autumn Meeting of the Japanese Society of Gastroenterology September 20–24, 1993, Kobe, Japan (2008) (0)
A Case of Inflammatory Hepatocellular Adenoma Complicated by Steatohepatitis (2014) (0)
Aberration of the p53 gene in human pancreatic ductal adenocarcinomas (1993) (0)
TWO CASES OF ESOPHAGEAL PAPILLOMA (1986) (0)
Esophageal leiomyoblastoma: the role of endoscopic procedures in the pre-operative diagnosis. (1993) (0)
[Genetic variability and clinical significance of hypervariable region of hepatitis C virus]. (2004) (0)
Forefront of radiofrequency ablation treatment of hepatic cancer. 6. Combination of RFA and another treatment. (2005) (0)
[Hepatocellular carcinoma]. (2020) (0)
EXPERIENCES WITH EMERGENT ENDOSCOPY FOR UPPER GASTROINTESTINAL BLEEDING (1981) (0)
TENTATIVE RESULT OF INJECTION SCLEROTHERAPY AND PROGNOSIS FOR ESOPHAGEAL VARICES (1983) (0)
Killer cell (k-cell) population in chronic liver disease (2007) (0)
[Frontier of the treatment of hepatocellular carcinoma]. (2005) (0)
First Digestive Disease Week of Japan and Thirty-Fifth Annual Autumn Meeting of the Japanese Society of Gastroenterology September 20–24, 1993, Kobe, Japan (2007) (0)
Interferon gamma treatment inhibits collagen deposition in pig serum-induced rat liver fibrosis in vivo (1995) (0)
Therapeutic effect of secretin in patients with jaundice; Double-blind placebo-controlled multicentric trial (1996) (0)
HCV/Oxidative Stress and Liver Disease (2003) (0)
Role of Epidermal Growth Factor in Protection, Repair and Healing of Gastroduodenal Mucosal Injury (1990) (0)
Increased expression and phosphorylation of liver glutamine synthetase in well‐differentiated hepatocellular carcinoma tissues from patients infected with hepatitis C virus (2006) (0)
Serum protein alteration in acute hepatic failure (1979) (0)
A Case of Brunner Gland Hyperplasia with Gastrointestinal Bleeding (2015) (0)
Liver cirrhosis.An advance on diagnosis and medical treatment.9.Complications with liver cirrhosis and their countermeasure.2.Esophagus varix. (1991) (0)
Promotive effect of phenobarbital through hepatocarcinogenesis by 2-fluorenylacetamide in rats (1979) (0)
Experimental Hepatocarcinogenesis and Its Prevention (1997) (0)
[A case of fulminant hepatitis with marked proliferation of so-called pseudo-bileduct seen in a baby (author's transl)]. (1980) (0)
TWO CASES OF COMMON DUCTAL STONES DELIVERED BY NON-INVASIVE METHOD IN THE CHILDREN OF ANOMALOUS ARRANGEMENT OF PANCREATICO-BILIARY DUCT (1993) (0)
Seventy-sixth general meeting of The Japanese Society of Gastroenterology March 29–31, 1990 — Tokyo, Japan (2007) (0)
An autopsy of a case of acute liver failure associated with adult-onset Still's disease. (1996) (0)
Subgroup analyses of a phase 1/2 study of lenvatinib (E7080), a multitargeted tyrosine kinase inhibitor, in patients (pts) with advanced hepatocellular carcinoma (HCC). (2017) (0)
[Diagnosis of Epstein-Barr virus-associated gastric carcinoma and its background gastric mucosa]. (1997) (0)
[Clinical evaluation of positive- and negative-stranded HCV-RNAs in liver in relation to IFN therapy]. (1995) (0)
P-46 Floating density of circulating hepatitis C viral particles in patients with hepatitis C virus infection (1995) (0)
Sixty-ninth annual meeting of the Japanese Society of Gastroenterology (2007) (0)
Impact of bodyweight‐based starting doses on the safety and efficacy of lenvatinib in primarily Japanese patients with hepatocellular carcinoma (2022) (0)
EXPERIENCE WITH NEWLY DEVELOPED POLYETHYLENE GLYCOL ELECTROLYTE LAVAGE SOLUTIONFOR PREMEDICATION AT COLONOSCOPY (1988) (0)
[Therapy of esophageal varices complicated with liver cirrhosis]. (1991) (0)
Abstracts of selected papers presented at the 74th general meeting of the Japanese Society of Gastroenterology (2007) (0)
TWO CASES OF COLUMNAR LINED ESOPHAGUS (1979) (0)
A Case of Safe Endoscopic Removal of a Gastric Bezoar (2004) (0)
Impact of bodyweight (BW)-based starting doses on safety and efficacy of lenvatinib (LEN) in patients (pts) with hepatocellular carcinoma (HCC). (2021) (0)
LAPAROSCOPIC STUDY OF LIVER SURFACE OF RAT DURING HEPATOCARCINOGENESIS WITH 2-ACETYLAMINOFLUORENE (1982) (0)
Liver regeneration by stem cells and the clinical application. (2006) (0)
Abstracts of selected papers presented at the 33rd Annual Meeting of the Japanese Society of Gastroenterology (2007) (0)
Role of the Carboxyl Terminus in the Regulation of Phosphatidylethanolamine N-methyltransferase ( PEMT ) (2004) (0)
[Proper dosage and ratio of supplementary insulin-glucagon for the management of liver failure]. (1982) (0)
A case of honeymoon hepatitis who died of fulminant hepatitis (1980) (0)
408 Hepatitis C virus core protein inhibits deoxycholic acid-induced apoptosis in spite of inducing oxidative stress (2003) (0)
Clinical course on patients with primary hepatocellular carcinoma surviving longer than one year. (1977) (0)
Development of an in vivo animal model to monitor the extracellular neural amino acids in the dorsal hippocampus during behavior disorder on acute liver failure (2005) (0)
CLINICAL EXPERIENCE WITH A NEW ENDOSCOPIC ULTRASOUNDPROBE COMBINING RADIAL AND LINEAR SCANNING FACILIITIES IN THE ESOPHAGUS AND STOMACH (1996) (0)
The Thirty-Third Annual Meeting of the Japanese Society of Gastroenterology October 24–26, 1991 — Kurume, Japan (2007) (0)
Therapy of intrahepatic cholestasis with secretin (1991) (0)
F8-7 Mechanism of ito cell activation in rat liver cirhosis induced by a choline-deficient (CD) diet and prevention of ito cell activation by prolyl 4-hydroxylase inhibitor (1995) (0)
HHM: A Dominant Inhibitory Helix-Loop-Helix Protein Associated with Liver-Specific Gene Expression and Liver Stem Cells (2002) (0)
First digestive disease week of japan and thirtyfifth annual autumn meeting of the Japanese Society of Gastroenterology September 20–24, 1993, Kobe, Japan (2007) (0)
[Diagnosis of small hepatocellular carcinoma and its prognosis]. (1999) (0)
[The validity of radiofrequency ablation for hepatocellular carcinoma]. (2004) (0)
Subject Index of the 7th Meeting of the European Association for the Study of the Liver with Number of Paper (1972) (0)
Hearing disorders and their early diagnosis (1968) (0)
International Hepatology Communications to become Hepatology Research (1997) (0)
PRELIMINARY STUDY OF THE LASER-ENDOSCOPE I, THE SIZE OF EXPOSED BLOOD VESSEL SEEN IN THE HEMORRHAGIC GASTRIC ULCER (1979) (0)
New prolyl 4-hydroxylase inhibitor inhibits pig serum-induced liver fibrosis by preventing ITO cell activation (1995) (0)
Genomics research in the liver. 5. Proteomics of hepatoma. (2005) (0)
[Proton pump inhibitor for maintenance therapy of peptic ulcer]. (1992) (0)
Abstracts of selected papers presented at the 30th Annual Meeting of the Japanese Society of Gastroenterology October 20–22, 1988 — Kagoshima, Japan (1991) (0)
FIBROSIS ACCELERATES HEPATOCARCINOGENESIS (2001) (0)
[Liver regeneration with stem cell transplantation and its clinical application]. (2006) (0)
A CASE OF BILOBED GALLBLADDER DIAGNOSED BY ERCP (1981) (0)
LAPAROSCOPIC OBSERVATIONS OF A PATIENT WITH TUBERCULOUS PERITONITIS (1983) (0)
Effects of calcium-ion on biliary excretion of loaded bile acid and ICG (1984) (0)
Abstracts of selected papers presented at the 78th general meeting of the Japanese Society of Gastroenterology (1993) (0)
[Possibility of early therapy of hepatic cancer - trends in new diagnosis and therapy]. (1980) (0)
Hepatocellular Carcinoma with Invasion of the Right Intrahepatic Bile Duct Observed by Peroral Cholangioscopy: a Case Report (1990) (0)
813 Cytochrome-C is the possible new marker for the patients with acute liver failure (2003) (0)
23 Fibroblast growth factors enhance the transdifferentiation and proliferation of bone marrow cells into hepatocytes (2003) (0)
Inhibitory Effects of the Herbal Medicine Sho-saiko-to on Liver Fibrosis (2001) (0)
Strategy for the Development of Cell Therapy Using Bone Marrow Cells to Repair Damaged Liver (2004) (0)
Increase of T cells in the liver during hepatocarcinogenesis with N-2-fluorenylacetamide in rats. (1981) (0)
Photosensitive dermatitis due to Photofrin (2000) (0)
EXPERIENCE WITH NEWLY DEVELOPED PAN-ENDOSCOPE WITH CONVERTIBLE LENS SYSTEM AND BIOPSY CHANNEL, PFS-B1200II (1977) (0)
ELECTRONIC ENDOSCOPIC OBSERVATION OF DUODENAL VILLI IN PATIENTS WITH DUODENAL ULCER (1990) (0)
First Digestive Disease Week of Japan and Thirty-Fifth Annual Autumn Meeting of the Japanese Society of Gastroenterology September 20–24, 1993, Kobe, Japan (2007) (0)
Comparison of various precipitin tests in the detection of alpha-fetoprotein in serum. (1972) (0)
Special issue : Chronic hepatitis : Advances in diagnosis and treatment.3.Recent treatment.4.Treatment of inactive chronic hepatitis. (1994) (0)
A CASE OF HEPATOCELLULAR CARCINOMA WITH INVASION TO THE DUODENAL BULB (1996) (0)
73 Leptin receptor-deficient zucker (FA/FA) rat retards the development of pig serum-induced liver fibrosis with Kupffer cell dysfunction (2003) (0)
THE GASTRIC MUCOSA SURROUNDING EPSTEIN-BARR VIRUS-ASSOCIATED GASTRIC CANCERS (1998) (0)
[Balloon-occluded radiofrequency ablation for patients with hepatocellular carcinoma]. (2001) (0)
Hepatocellular carcinoma with Hemobilia and Obstructive Jaundice (1989) (0)
Molecular Targeted Therapy in HCC -Japanese Perspective- (2009) (0)
Proceedings of the 69th General Meeting from April 11–13, 1983-Osaka, Japan (1984) (0)
[Purification of human microsomal epoxide hydrolase and study on its localization in hepatocellular carcinoma tissue]. (1984) (0)
3. HHM : A candidate transcription factor regulating lineage commitments of embryonic liver cells (2001) (0)
Identification of α-fetoprotein producing cells in the early stage of hepatocarcinogenesis with n-2-fluorenylacetamide in rat (1979) (0)
Choice of conservative therapeutic modalities for hepatocellular carcinoma. (1986) (0)
[Mechanism of action, indications and problems in using aethoxysklerol as a sclerosing agent in esophageal varices]. (1990) (0)
[Gastric cancer with hepatic metastasis showing immunofluorescent localization of tumor markers]. (1983) (0)
[Application and limitation of endoscopic polypectomy in stomach polyps]. (1992) (0)
[Cytokines and liver fibrosis]. (2000) (0)
Studies of α‐Fetoprotein in Childhood (1972) (0)
F9-1 Hepatocellular carcinoma in Japan (1995) (0)
γ-Glutamyltranspeptidase isozyme in hepatocellular carcinoma (1980) (0)
The “Stent through Stent Technique” for Hilar Malignant Stenosis Complicated with Common Bile Duct Calculi (1994) (0)
Abstracts from the Medical Literature (1972) (0)
[Hepatocarcinogenesis with chemicals including mycotoxins]. (2001) (0)
Percutaneous hot water injection and microwave coagulation therapy for hepatocellular carcinoma (1998) (0)
RELATIONSHIPS BETWEEN ENDOSCOPIC FINDINGS OF ESOPHAGEAL VARICES AND CLINICAL FINDINGS. (1978) (0)
Hepatitis B Virus Carrier Status Linked to AutoimmuneHepatitis (2007) (0)
[The immunofluorescence study of gastrin producing cell in the intermediate zone of gastric mucosa. I. Its relationship to the atrophic border of atrophic gastritis (author's transl)]. (1979) (0)
Hepatology Research: from the 3rd to 4th generation (1998) (0)
[Specificity of -fetoprotein of primary hepatoma]. (1972) (0)
EXPERIMENTAL STUDY FOR SIDE EFFECTS OF METHYLENE BLUE (1979) (0)
Long-term results of metallic stenting for malignant biliary stricture (1995) (0)
Different Quasispecies of Hepatitis C Virus in Human Serum, Peripheral Blood Mononuclear Cells, and Liver (1999) (0)
[Treatment of refractory ascites]. (1985) (0)
Symposia(1)Molecular Approach for Pathophysiology of Digestive Diseases (2003) (0)
Membrane change in the early stage of D-galactosamine induced hepatic injury (1978) (0)
[Clinical trial of protease inhibitor in the treatment of fulminant hepatitis]. (1991) (0)
Iron Chelation by Deferoxamine Prevents Hepatocarcinogenesis (2001) (0)
[Study on autofluorescence of experimental liver cancer excited by laser light (author's transl)]. (1981) (0)
Pancreatic Sphincterotomy and Pure Pancreatic Juice Collection for Treatment of Chronic Pancreatitis (1990) (0)
The effect of E3330 on active oxygen generation by isolated hepatic macrophages in rats (1995) (0)
LAPAROSCOPIC EXAMINATION OF CHRONIC LIVER DISEASES (1981) (0)
Studies for bile retention produced by choledocho-caval fistula in rats. Possible model for intrahepatic cholestasis. (1989) (0)
Long-term administration of heterogenous interferon results in a loss of its biological effect. (1999) (0)
Author reply (0)
Effects of ranitidine on plasma clearance of indocyanine green in patients with liver cirrhosis (1987) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Kiwamu Okita?

Kiwamu Okita is affiliated with the following schools:

Yamaguchi University